GNRX
VanEck Vectors Generic Drugs ETF
GNRX
GNRX
Delisted
GNRX was delisted on the 4th of April, 2019.
4 hedge funds and large institutions have $732K invested in VanEck Vectors Generic Drugs ETF in 2017 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
–
Holders Change %
0%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$259K |
| 2 |
Jane Street
New York
|
+$8.17K |
Top Sellers
| 1 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
-$25.3K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Jane Street
New York
| $271K | +$8.17K | +336 | +3% |
|
|
2
Citadel Advisors
Miami,
Florida
| $259K | +$259K | +10,661 | New |
|
|
APA
3
American Portfolios Advisors
Holbrook,
New York
| $178K | +$178K | +7,311 | New |
|
4
Bank of America
Charlotte,
North Carolina
| $24K | – | – | – |
|
|
FDCDDQ
5
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| – | -$25.3K | -1,141 | Closed |
|
|
6
UBS Group
Zurich,
Switzerland
| – | -$1K | -50 | Closed |
|